Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Today 4:06 PM View:  | McLaughlin Kevin F Director | Aastrom Biosciences, Inc. (VCEL) | 01-May-24 | Option Exercise | 3,200 | -- | -- | 37% 8.7K to 11.9K | |
| Today 4:06 PM View: | Hagen Heidi Director | Aastrom Biosciences, Inc. (VCEL) | 01-May-24 | Option Exercise | 3,200 | -- | -- | 21% 15.45K to 18.65K | |
| Today 4:06 PM View: | Zerbe Robert L Md Director | Aastrom Biosciences, Inc. (VCEL) | 01-May-24 | Option Exercise | 3,200 | -- | -- | 14% 23.39K to 26.59K | |
| Today 4:06 PM View: | Wotton Paul K Director | Aastrom Biosciences, Inc. (VCEL) | 01-May-24 | Option Exercise | 3,200 | -- | -- | 12% 26.8K to 30.0K | |
| Today 4:06 PM View: | Wright Lisa Director | Aastrom Biosciences, Inc. (VCEL) | 01-May-24 | Option Exercise | 3,200 | -- | -- | 55% 5.82K to 9.02K | |
| Today 4:06 PM View: | Rubino Alan L Director | Aastrom Biosciences, Inc. (VCEL) | 01-May-24 | Option Exercise | 3,200 | -- | -- | 16% 20.59K to 23.79K | |
| Today 4:06 PM View: | Gilman Steven C Director | Aastrom Biosciences, Inc. (VCEL) | 01-May-24 | Option Exercise | 3,200 | -- | -- | 41% 7.8K to 11.0K | |
| 01-May-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 30-Apr-24 | Option Exercise | 25,445 | $11.79 | $299,977.00 | 13% 195.31K to 220.75K | |
| 19-Apr-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 18-Apr-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 9% 195.31K to 212.81K | |
| 19-Apr-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 18-Apr-24 | Option Sale | 17,500 | $44.59 | $780,325.00 | (8%) 212.81K to 195.31K | |
| 19-Apr-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 17-Apr-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 9% 195.31K to 212.81K | |
| 19-Apr-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 17-Apr-24 | Option Sale | 17,500 | $46.47 | $813,225.00 | (8%) 212.81K to 195.31K | |
| 11-Apr-24 4:05 PM View: | Rubino Alan L Director | Aastrom Biosciences, Inc. (VCEL) | 09-Apr-24 | Option Exercise | 3,000 | $4.12 | $12,360.00 | 17% 17.59K to 20.59K | |
| 29-Mar-24 4:05 PM View: | Zerbe Robert L Md Director | Aastrom Biosciences, Inc. (VCEL) | 27-Mar-24 | Option Sale | 3,278 | $51.57 | $169,046.00 | (12%) 26.67K to 23.39K | |
| 29-Mar-24 4:05 PM View: | Zerbe Robert L Md Director | Aastrom Biosciences, Inc. (VCEL) | 27-Mar-24 | Option Exercise | 3,278 | $3.74 | $12,259.70 | 14% 23.39K to 26.67K | |
| 15-Mar-24 4:07 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 14-Mar-24 | Option Sale | 17,500 | $44.02 | $770,350.00 | (8%) 212.37K to 194.87K | |
| 15-Mar-24 4:07 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 14-Mar-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 9% 194.87K to 212.37K | |
| 15-Mar-24 4:07 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 13-Mar-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 9% 194.87K to 212.37K | |
| 15-Mar-24 4:07 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 13-Mar-24 | Option Sale | 17,500 | $44.67 | $781,725.00 | (8%) 212.37K to 194.87K | |
| 13-Mar-24 4:05 PM View: | Halpin Michael Chief Operating Officer | Aastrom Biosciences, Inc. (VCEL) | 11-Mar-24 | Private Sale | 7,874 | $44.71 | $352,047.00 | (89%) 8.82K to 0.95K | |
| 11-Mar-24 4:07 PM View: | Flynn Sean C. SVP, General Counsel | Aastrom Biosciences, Inc. (VCEL) | 08-Mar-24 | Private Sale | 8,115 | $45.33 | $367,853.00 | (98%) 8.28K to 0.17K | |
| 11-Mar-24 4:08 PM View: | Siegal Jonathan Principal Accounting Officer | Aastrom Biosciences, Inc. (VCEL) | 07-Mar-24 | Private Sale | 1,634 | $45.00 | $73,530.00 | (54%) 3.03K to 1.4K | |
| 22-Feb-24 4:07 PM View: | Flynn Sean C. SVP, General Counsel | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Option Exercise | 7,075 | -- | -- | 159% 4.46K to 11.53K | |
| 22-Feb-24 4:06 PM View: | Siegal Jonathan Principal Accounting Officer | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Payment of Exercise | 1,286 | $49.50 | $63,657.00 | (30%) 4.32K to 3.03K | |
| 22-Feb-24 4:07 PM View: | Halpin Michael Chief Operating Officer | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Option Exercise | 11,887 | -- | -- | 446% 2.67K to 14.55K | |
| 22-Feb-24 4:06 PM View: | Mara Joseph Anthony Jr Chief Financial Officer | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Payment of Exercise | 2,268 | $49.50 | $112,266.00 | (11%) 21.56K to 19.29K | |
| 22-Feb-24 4:06 PM View: | Hopper Jonathan Mark Chief Medical Officer | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Option Exercise | 7,075 | -- | -- | 13% 53.98K to 61.06K | |
| 22-Feb-24 4:07 PM View: | Zerbe Robert L Md Director | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Option Exercise | 722 | $3.74 | $2,700.28 | 3% 23.39K to 24.12K | |
| 22-Feb-24 4:07 PM View: | Zerbe Robert L Md Director | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Option Sale | 722 | $50.01 | $36,107.20 | (3%) 24.12K to 23.39K | |
| 22-Feb-24 4:06 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Payment of Exercise | 18,025 | $49.50 | $892,238.00 | (8%) 212.9K to 194.87K | |
| 22-Feb-24 4:06 PM View: | Siegal Jonathan Principal Accounting Officer | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Option Exercise | 2,920 | -- | -- | 209% 1.4K to 4.32K | |
| 22-Feb-24 4:07 PM View: | Halpin Michael Chief Operating Officer | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Payment of Exercise | 5,731 | $49.50 | $283,684.00 | (39%) 14.55K to 8.82K | |
| 22-Feb-24 4:07 PM View: | Flynn Sean C. SVP, General Counsel | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Payment of Exercise | 3,250 | $49.50 | $160,875.00 | (28%) 11.53K to 8.28K | |
| 22-Feb-24 4:06 PM View: | Hopper Jonathan Mark Chief Medical Officer | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Payment of Exercise | 3,106 | $49.50 | $153,747.00 | (5%) 61.06K to 57.95K | |
| 22-Feb-24 4:06 PM View: | Mara Joseph Anthony Jr Chief Financial Officer | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Option Exercise | 7,380 | -- | -- | 52% 14.18K to 21.56K | |
| 22-Feb-24 4:06 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 20-Feb-24 | Option Exercise | 38,887 | -- | -- | 22% 174.01K to 212.9K | |
| 16-Feb-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 15-Feb-24 | Option Sale | 17,500 | $48.85 | $854,875.00 | (9%) 191.51K to 174.01K | |
| 16-Feb-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 15-Feb-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 10% 174.01K to 191.51K | |
| 16-Feb-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 14-Feb-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 10% 174.01K to 191.51K | |
| 16-Feb-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 14-Feb-24 | Option Sale | 17,500 | $46.99 | $822,325.00 | (9%) 191.51K to 174.01K | |
| 13-Feb-24 4:05 PM View: | Halpin Michael Chief Operating Officer | Aastrom Biosciences, Inc. (VCEL) | 12-Feb-24 | Option Exercise | 3,500 | -- | -- | 369% 0.95K to 4.45K | |
| 13-Feb-24 4:06 PM View: | Hopper Jonathan Mark Chief Medical Officer | Aastrom Biosciences, Inc. (VCEL) | 12-Feb-24 | Option Exercise | 1,625 | -- | -- | 3% 53.13K to 54.76K | |
| 13-Feb-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 12-Feb-24 | Payment of Exercise | 3,477 | $47.42 | $164,879.00 | (2%) 177.49K to 174.01K | |
| 13-Feb-24 4:05 PM View: | Halpin Michael Chief Operating Officer | Aastrom Biosciences, Inc. (VCEL) | 12-Feb-24 | Payment of Exercise | 1,782 | $47.42 | $84,502.40 | (40%) 4.45K to 2.67K | |
| 13-Feb-24 4:06 PM View: | Hopper Jonathan Mark Chief Medical Officer | Aastrom Biosciences, Inc. (VCEL) | 12-Feb-24 | Payment of Exercise | 775 | $47.42 | $36,750.50 | (1%) 54.76K to 53.98K | |
| 13-Feb-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 12-Feb-24 | Option Exercise | 7,500 | -- | -- | 4% 169.99K to 177.49K | |
| 30-Jan-24 4:05 PM View: | Zerbe Robert L Md Director | Aastrom Biosciences, Inc. (VCEL) | 29-Jan-24 | Private Sale | 2,300 | $44.22 | $101,706.00 | (9%) 25.7K to 23.39K | |
| 29-Jan-24 4:05 PM View: | Zerbe Robert L Md Director | Aastrom Biosciences, Inc. (VCEL) | 25-Jan-24 | Private Sale | 200 | $44.02 | $8,804.00 | (< 1%) 25.89K to 25.7K | |
| 24-Jan-24 4:05 PM View: | Zerbe Robert L Md Director | Aastrom Biosciences, Inc. (VCEL) | 22-Jan-24 | Sale | 5,000 | $41.85 | $209,234.00 | (16%) 30.89K to 25.89K | |
| 24-Jan-24 4:05 PM View: | Zerbe Robert L Md Director | Aastrom Biosciences, Inc. (VCEL) | 22-Jan-24 | Option Exercise | 3,000 | $4.12 | $12,360.00 | 10% 30.89K to 33.9K |
